Epidemiology of Guillain-Barré syndrome in the province of Quebec

Can J Neurol Sci. 2008 Sep;35(4):472-5. doi: 10.1017/s0317167100009136.

Abstract

Background: In the province of Quebec, a population-based study of Guillain-Barré syndrome (GBS) was conducted at the time of a mass immunization campaign against meningococcal disease, in 2001.

Methods: The study population included residents aged 2 months to 20 years observed from November 1st, 2000 to December 31, 2002, representing 4,075,465 person-years of observation. GBS cases were identified in the provincial hospital database Med-Echo and medical records were reviewed.

Results: Thirty-three incident GBS cases were identified, including 27 cases of acute inflammatory demyelinating polyradiculopathy. The overall GBS incidence rate was 0.8/100,000 person-years, higher in persons aged 1 to 4 years (2.1/100,000) than in those 5 years or more (0.6/100,000). There was a female preponderance and no significant seasonal variation. All patients survived.

Conclusion: Results could be used to interpret reports of adverse events associated with the introduction of new vaccines in this age-group in Canada.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Female
  • Guillain-Barre Syndrome / diagnosis
  • Guillain-Barre Syndrome / epidemiology*
  • Guillain-Barre Syndrome / etiology
  • Guillain-Barre Syndrome / physiopathology
  • Humans
  • Infant
  • Male
  • Meningococcal Infections / complications
  • Meningococcal Infections / prevention & control
  • Meningococcal Vaccines / adverse effects
  • Quebec / epidemiology

Substances

  • Meningococcal Vaccines